The science and research behind IQOS.
Our scientific assessment journey.
Our scientific assessment journey.
We have developed a comprehensive step-by-step scientific assessment programme. This programme is inspired by the practices of the pharmaceutical industry and is in line with the USA’s Federal Drug Administration’s 2012 guidance on the assessment of candidate Modified Risk Tobacco products. Our assessment was also conducted according to international standards.
In laboratory settings, we found that IQOS’ tobacco vapour is less toxic than cigarette smoke. Our scientists test our products thoroughly before they go into adult smokers’ hands. Using in vitro assays in our labs, we assessed the cytotoxicity and genotoxicity of IQOS tobacco vapor in comparison with the smoke of a reference cigarette designed for research purposes. Taken together, the results of these assays show that IQOS tobacco vapour is significantly less toxic than the smoke from reference cigarette.
This is just a glimpse of our work. These tests were crucial before we moved on to test IQOS with thousands of adult smokers who voluntarily participated in our clinical study programme and ultimately allowed us to commercialize our products.
This product is not risk free and provides nicotine, which is addictive. Only
for use by adults
Helpful Links
© 2022 Philip Morris Products SA
Please enter your date of birth to confirm you are an adult user of nicotine or tobacco products.
Sorry!
This website is intended only for users of nicotine or tobacco products who are over 18.
We care
This site contains information about products sold in the Republic of Kyrgyzstan for consumers who are smokers and over 18 years old. By continuing to use the site, you confirm that you wish to get acquainted with the necessary information about the manufacturer (seller) and the goods sold by it, in accordance with the legislation of the Kyrgyz Republic.
Country redirect
Please note this site is intended for Kyrgyzstan. In order to ensure compliance with local legal requirement, we need to redirect you to your country of origin.
CONTINUE